Colorectal Cancer clinical trials in Iowa

7 actively recruiting colorectal cancer trials at 17 sites across Iowa.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 3 Recruiting Network

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

This phase III trial evaluates whether a web-based intervention called Current Together after Cancer (CTAC) works to increase the number of patients with surgically removed (resected) colorectal cancer who receive surveillance care that al…

Sponsor: SWOG Cancer Research Network

NCT ID: NCT07018869

Sites in Iowa:

UI Health Care Mission Cancer and Blood - Ankeny Clinic — Ankeny, Iowa
Saint Anthony Regional Hospital — Carroll, Iowa
Physicians' Clinic of Iowa PC — Cedar Rapids, Iowa
Mercy Hospital — Cedar Rapids, Iowa
Oncology Associates at Mercy Medical Center — Cedar Rapids, Iowa

View on ClinicalTrials.gov →

Phase 3 Recruiting Academic/Other

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

This phase III trial compares total ablative therapy and usual systemic therapy to usual systemic therapy alone in treating patients with colorectal cancer that has spread to up to 4 body sites (limited metastatic). The usual approach for …

Sponsor: Alliance for Clinical Trials in Oncology

NCT ID: NCT05673148

Sites in Iowa:

UI Health Care Mission Cancer and Blood - Ankeny Clinic — Ankeny, Iowa
University of Iowa Healthcare Cancer Services Quad Cities — Bettendorf, Iowa
Mercy Cancer Center-West Lakes — Clive, Iowa
UI Health Care Mission Cancer and Blood - West Des Moines Clinic — Clive, Iowa
Greater Regional Medical Center — Creston, Iowa

View on ClinicalTrials.gov →

Phase 1, Phase 2 Recruiting Industry

Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions

This is a Phase 1/2, multi-center, open-label basket study designed to evaluate the safety and anti-tumor activity of IDE196 in patients with solid tumors harboring GNAQ or GNA11 (GNAQ/11) mutations or PRKC fusions, including metastatic uv…

Sponsor: IDEAYA Biosciences

NCT ID: NCT03947385

Sites in Iowa:

University of Iowa — Iowa City, Iowa

View on ClinicalTrials.gov →

Phase 1, Phase 2 Recruiting Industry

A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors

The purpose of this study is to assess the safety, tolerability, and recommended dose(s) of BMS-986340 as monotherapy and in combination with nivolumab or docetaxel in participants with advanced solid tumors. This study is a first-in-human…

Sponsor: Bristol-Myers Squibb

NCT ID: NCT04895709

Sites in Iowa:

University of Iowa — Iowa City, Iowa

View on ClinicalTrials.gov →

Phase 1 Recruiting Industry

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

This is a first-in-human Phase 1b, 2-part, multicenter open-label clinical study to evaluate safety and efficacy of a Nectin-4 radiopharmaceutical (\[225Ac\]Ac-AKY-1189) in patients with locally advanced or metastatic solid tumors and to e…

Sponsor: Aktis Oncology, Inc.

NCT ID: NCT07020117

Sites in Iowa:

University of Iowa — Iowa City, Iowa

View on ClinicalTrials.gov →

Recruiting Academic/Other

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in th…

Sponsor: Alliance for Clinical Trials in Oncology

NCT ID: NCT05334069

Sites in Iowa:

Mary Greeley Medical Center — Ames, Iowa
McFarland Clinic - Ames — Ames, Iowa
UI Health Care Mission Cancer and Blood - Ankeny Clinic — Ankeny, Iowa
McFarland Clinic - Boone — Boone, Iowa
Mercy Hospital — Cedar Rapids, Iowa

View on ClinicalTrials.gov →

Recruiting Industry

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinic…

Sponsor: Massive Bio, Inc.

NCT ID: NCT03452774

Sites in Iowa:

Massive Bio SYNERGY-AI site — Iowa City, Iowa

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20